Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01827332 · ClinicalTrials.gov registry record · NA
Effect of Oxytocin on Craving and Therapy Response
A NA study of Marijuana Dependence, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- NA
- Development phase
- 16
- Enrollment target
- 1
- Study location
NCT01827332: Completed NA study of Marijuana Dependence, sponsored by Medical University of South Carolina.
NCT01827332 is a NA study of Marijuana Dependence that has completed, run by Medical University of South Carolina. The registered enrollment target is 16 participants, below the 90-participant average among 6 other Marijuana Dependence trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01827332, a NA study of Marijuana Dependence, has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to examine the impact of a medication called oxytocin on marijuana use and therapy response in people who frequently use marijuana.
Primary Outcome
After MET sessions, subjects completed the Session Rating Scale (SRS, Miller et al). This visual analog scale is comprised of 4 items for which participants rate their therapy experience in terms of relationship, goals and topics, approach/method, and overall, with minimum score 0 representing most dissatisfied and maximum score 10 representing most satisfied. Outcome measure reported below represents SRS score at last MET session.
Conditions Studied
Interventions
- DRUG Saline
- DRUG Oxytocin
Study Locations (1)
South Carolina
- Medical University of South Carolina - Charleston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2013-03 |
| Est. Completion | 2016-07 |
| Phase | NA |
What the finished NCT01827332 record still lists
NCT01827332 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 16 participants, a relatively small participant target, below the 90-participant average among 6 other Marijuana Dependence trials with a reported enrollment target (82% lower).
The record links to 1 condition, with Marijuana Dependence appearing as the primary indexed condition, and to 2 interventions - of which Saline is the first listed.
NCT01827332 reports a single indexed study location in South Carolina.
Frequently Asked Questions
What is clinical trial NCT01827332 about?
NCT01827332 is a clinical study titled "Effect of Oxytocin on Craving and Therapy Response". The purpose of this study is to examine the impact of a medication called oxytocin on marijuana use and therapy response in people who frequently use marijuana.
What is the current status of trial NCT01827332?
This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2013-03. Estimated completion is 2016-07.
What conditions does trial NCT01827332 study?
This clinical trial studies the following conditions: Marijuana Dependence.
What interventions are being tested in trial NCT01827332?
The interventions under investigation include: Saline (DRUG), Oxytocin (DRUG).
Who is sponsoring clinical trial NCT01827332?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01827332 being conducted?
This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Marijuana Dependence
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Marijuana Treatment Project 4
COMPLETED · NA
-
Effect of Oxytocin on Stress in Marijuana Users
COMPLETED · NA
-
Vilazodone Treatment for Marijuana Dependence
COMPLETED · Phase 2
-
Effect of Baclofen on Marijuana Withdrawal and Relapse
COMPLETED · Phase 2
-
Buspirone Treatment for Marijuana Dependence
COMPLETED · Phase 4
-
Effectiveness Study of Dronabinol and BRENDA for the Treatment of Cannabis Withdrawal
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02422641 · 16 participants · Phase 2
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
- NCT02851758 · 16 participants · NA
Transplantation of Autologously Derived Mitochondria Following Ischemia
- NCT03291028 · 16 participants
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
- NCT03425526 · 16 participants · Phase 1
Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia